It was shown that in early stroke NLRP1, NLRC4 or AIM2 did not have significant effects, while NLRP3 was predominantly expressed in ischemic neurons, and its inhibition improved neurologic outcome with a reduction in infarct size [117]. Here, AIM2 is linked to stroke disorder.